http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2884257-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a7e8438eee83a9a598fec98a59673ef |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-142 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-32 |
| filingDate | 2005-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40ea03d35744dd9981e378d4183b5b07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd7f825545658e809993b7eeca2bb3ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acbc1538024ac5d699eeadd3234813e6 |
| publicationDate | 2006-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-2884257-A1 |
| titleOfInvention | PREVENTION OF TOXICITIES DUE TO 5-FLUOROURACILE |
| abstract | In vitro diagnostic method for increased sensitivity to 5-fluorouracil, said method comprising carrying out on one or more biological samples, including at least one blood sample, the combination of at least two in vitro tests chosen from the group consisting of the measurement of plasma uracil concentration, the measurement of the dihydrouracil / uracil plasma concentration ratio, and the determination of the presence or absence of a mutation in the gene encoding Dihydropyrimidine Dehydrogenase. It also relates to an in vitro diagnostic method for the predisposition of a subject to the development of toxicity following a treatment comprising 5-fluorouracil, as well as a method for in vitro evaluation of the dose of 5-fluorouracil. -Fluorouracile adapted to a patient with a disease that can be treated with 5-fluorouracil. |
| priorityDate | 2005-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 262.